2. Signaling Pathways
  3. Metabolic Enzyme/Protease
  4. Liposome
  5. Liposome Chemical

Liposome Chemical

Liposome Chemicals (8):

Cat. No. Product Name Effect Purity
  • HY-145799
    5A2-SC8
    		Chemical 99.19%
    5A2-SC8 is an ionizable amino lipid in lipid nanoparticles (LNPs) that shows high delivery potential and low in vivo toxicity, enabling efficient delivery of small RNAs such as siRNA and miRNA into tumor cells. 5A2-SC8 LNPs can confer a unique delivery fate of RNA within the liver, thereby changing the therapeutic outcomes in cancer models.
  • HY-156857
    PPZ-A10
    		Chemical ≥98.0%
    PPZ-A10 is a ionizable lipid that delivered mRNA preferentially to liver and spleen immune cells.
  • HY-112768
    PEG2000-DMPE
    		Chemical
    PEG2000-DMPE can be used to synthsis a LNP. PEG2000-DMPE enhances the entrapment efficiency depending on the increasing portion in the liposome. The optimal formulation for animal study is that DMPC/PEG2000-DMPE/CH=50/5/45 at the weight ratio of drug/lipid=1/20.
  • HY-138622
    24:0 Lyso PC
    		Chemical 99.70%
    24:0 Lyso PC is a lysophospholipid (LyP). 24:0 Lyso PC could be used for mRNA drug delivery.
  • HY-145225
    DLin-K-C3-DMA
    		Chemical 98.59%
    DLin-K-C3-DMA, a cationic lipid, can be used in the synthesis of nucleic acid-lipid particle to delivery of nucleic acid.
  • HY-160705
    PNI 132
    		Chemical
    PNI 132, an ionizable lipid derived from the patent WO2020252589A, is useful in the formulation of lipid nanoparticles.
  • HY-160569
    C14-SPM
    		Chemical
    C14-SPM is a polyamine branched-chain lipidoid that can be used for the delivery of siRNA.
  • HY-145799A
    5A2-SC8 TFA
    		Chemical 98.56%
    5A2-SC8 TFA is an ionizable amino lipid in lipid nanoparticles (LNPs) that shows high delivery potential and low in vivo toxicity, enabling efficient delivery of small RNAs such as siRNA and miRNA into tumor cells. 5A2-SC8 TFA LNPs can confer a unique delivery fate of RNA within the liver, thereby changing the therapeutic outcomes in cancer models.